News
- Author:
- Christine Kilgore
Publish date: August 24, 2022
The reasons for the difference are unclear and in need of further research, according to the study authors.
News
- Author:
- Christine Kilgore
Publish date: August 5, 2022
In the phase 2 study, improvements in the Cutaneous Lupus Erythematosus Disease Area and Severity Index–Activity score were seen in patients random...
News
- Author:
- Christine Kilgore
Publish date: July 22, 2022
Experts advise screening questionnaires, more attentive conversations, as well as pulmonary rehab and cognitive behavioral therapy.
News
- Author:
- Christine Kilgore
Publish date: June 28, 2022
There’s an increased incidence of keratinocyte carcinoma in children who receive a solid-organ transplant, but it does not tend to develop until yo...
News
- Author:
- Christine Kilgore
Publish date: May 20, 2022
“The bird’s eye view is that obesity completely changes lung health.”
News
- Author:
- Christine Kilgore
Publish date: May 17, 2022
Patients taking lenabasum experienced greater reductions in the Cutaneous Dermatomyositis Disease Area and Severity Index, compared with those on p...
News
- Author:
- Christine Kilgore
Publish date: April 27, 2022
“The benefit of Filsuvez is its ability to promote healing of EB partial thickness wounds,” the EMA said in an announcement.
News
- Author:
- Christine Kilgore
Publish date: April 21, 2022
Diet’s impact on the microbiome is exceedingly difficult to tease apart and characterize in human studies.
News
- Author:
- Christine Kilgore
Publish date: April 1, 2022
After treatment, each of the children had increased, sustained expression of laminin 332.
News
- Author:
- Christine Kilgore
Publish date: March 31, 2022
Diet’s impact on the microbiome is exceedingly difficult to tease apart and characterize in human studies.
News
- Author:
- Christine Kilgore
Publish date: March 26, 2022
Analyses have shown differences in the gut microbiome between patients with IBS and healthy controls, as well as among IBS subgroups.
News
- Author:
- Christine Kilgore
Publish date: March 24, 2022
Precision medicine – which aims to tailor treatments to defined subgroups of patients – needs to take into account “much more than the human genome...
News
- Author:
- Christine Kilgore
Publish date: March 24, 2022
Preventive treatments for C. diff recurrence are in phase 3 trials, and oncologists are investigating microbiome-based differences in trea...
News
- Author:
- Christine Kilgore
Publish date: March 18, 2022
Preventive treatments for C. diff recurrence are in phase 3 trials, and oncologists are investigating microbiome-based differences in trea...
News
- Author:
- Christine Kilgore
Publish date: February 22, 2022
The data are “reassuring,” the authors reported.
